Scout | RFA-DK-26-306: Engineering Improved Stem Cell-Derived Islet Cells for Replacement Therapies (R01

nofo RFA-DK-26-306

Engineering Improved Stem Cell-Derived Islet Cells for Replacement Therapies (R01 - Clinical Trial Not Allowed)

This funding opportunity is designed to support research in understanding how to engineer intrinsic characteristics of stem cell-derived islet cell products that can result in improved cell replacement therapy outcomes. Unlike cadaveric human islets, stem cell-derived islet cell products are gen…

Funding Source

Agency: National Institutes of Health

Awards & funding

Total Funding: $3M

Award Ceiling: $500,000

Eligibility

Native American tribal organizations (other than Federally recognized tribal governments)

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

Public and State controlled institutions of higher education

Small businesses

State governments

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are no…

Documents

RFA-DK-26-306-Full-Announcement.html

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers